University of California San Francisco
Give to UCSFAt the recent June Precision Medicine World Conference, scientists and health experts from academia, government, and industry discussed how a precision medicine approached has helped to curb the pandemic and how lessons learned can be used to build resilience against future threats.
T cells – immune cells that patrol our bodies in search of trouble – have become a central focus for UC San Francisco scientists working on living cell therapies, an approach that views cells
The B.1.1.7 coronavirus variant—also known as Alpha—may be more infectious because it contains mutations that make it better adapted to foil the innate immune system, at least for long enough to allow the virus to replicate and potentially find new hosts, according to a new study.
UCSF is launching a new initiative to propel the development of living therapeutics – a category of treatments broadly defined as human and microbial living cells that are selected, modified, or engineered to treat or cure disease – and bring them quickly to patients.
Leading scientists share some of the tools and strategies that could help us better confront and contain future outbreaks.
Insomnia is miserable, and lost sleep can harm our health. Now, researchers are seeing the promise of solutions in our genes.
Hidden autoimmunity may explain how the coronavirus wreaks such widespread and unpredictable harm.
Cognitive behaviorial therapy for insomnia, the gold-standard intervention, also suggests benefits for well-being.
Scientists now have shown that the weakening of an astronaut’s immune system during space travel is likely due in part to abnormal activation of immune cells called T regulator cells.
A multifaceted collaboration between researchers at UCSF, Gladstone Institutes, and other organizations across California provides a comprehensive portrait of the variant—including its interaction with the immune system and its potential to spread.
UCSF researchers have found a way to double doctors’ accuracy in detecting the vast majority of complex fetal heart defects in utero.
UCSF experts will showcase how taking a precision medicine approach helped to combat the COVID-19 pandemic during the Precision Medicine World Conference on June 14-18.
The partnership will allow the company and the University to develop technology that will enable a modern, more streamlined experience for patients and set a new standard for health care delivery.
Six health care experts grapple with how to address race without being racist.
UCSF researchers have created a CRISPR technique to study how turning on or off single genes affects the function of different cell types and how these changes play a role in disease.
What kills most people who die from cancer is not the initial tumor. It’s the intolerable disease burden on the body that arises when tumor cells continually expand their numbers after spreading to different organs.
Scientists at UCSF are learning how immune cells naturally clear the body of defunct – or senescent – cells that contribute to aging and many chronic diseases
Pioneering neural recordings in patients with Parkinson’s disease by UCSF scientists are providing the groundwork for personalized brain stimulation to treat Parkinson’s and other neurological disorders.
A team at UCSF, in collaboration with colleagues at Stanford University, has unearthed the regulatory DNA sequences of our archaic human ancestors in a discovery that sheds light on how we diverged from them 500,000 years ago.
Researchers at UCSF have demonstrated how to engineer smart immune cells that are effective against solid tumors, opening the door to treating a variety of cancers that have long been untouchable with immunotherapies.
Three faculty members from UCSFhave been elected to the National Academy of Sciences (NAS), one of the highest honors accorded to American scientists.
Scientists have figured out how to modify CRISPR’s basic architecture to extend its reach beyond the genome and into what’s known as the epigenome.